114.80
前日終値:
$116.25
開ける:
$116.28
24時間の取引高:
1.19M
Relative Volume:
1.54
時価総額:
$6.45B
収益:
$633.51M
当期純損益:
$-8.10M
株価収益率:
-370.32
EPS:
-0.31
ネットキャッシュフロー:
$131.26M
1週間 パフォーマンス:
-5.38%
1か月 パフォーマンス:
-3.41%
6か月 パフォーマンス:
-31.63%
1年 パフォーマンス:
-7.28%
Repligen Corp Stock (RGEN) Company Profile
RGEN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RGEN
Repligen Corp
|
114.80 | 6.82B | 633.51M | -8.10M | 131.26M | -0.31 |
![]()
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-24 | 開始されました | Barclays | Overweight |
2025-04-29 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2025-03-18 | 開始されました | Evercore ISI | In-line |
2025-02-10 | 開始されました | TD Cowen | Buy |
2024-12-17 | 開始されました | Canaccord Genuity | Hold |
2024-11-14 | 開始されました | Wolfe Research | Peer Perform |
2024-08-28 | 開始されました | Wells Fargo | Overweight |
2024-06-26 | アップグレード | Deutsche Bank | Hold → Buy |
2024-06-18 | 開始されました | Guggenheim | Neutral |
2023-12-04 | ダウングレード | The Benchmark Company | Buy → Hold |
2023-07-20 | 開始されました | Wells Fargo | Overweight |
2023-07-05 | 再開されました | JP Morgan | Overweight |
2023-03-28 | 開始されました | The Benchmark Company | Buy |
2022-12-14 | 開始されました | Deutsche Bank | Hold |
2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
2022-07-20 | 開始されました | UBS | Buy |
2021-10-14 | 開始されました | Exane BNP Paribas | Outperform |
2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
2020-08-24 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-30 | 繰り返されました | H.C. Wainwright | Buy |
2020-05-07 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-23 | 繰り返されました | H.C. Wainwright | Buy |
2019-11-15 | 開始されました | Stifel | Buy |
2019-11-01 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
2019-10-15 | 開始されました | SVB Leerink | Outperform |
2019-08-28 | 繰り返されました | First Analysis Sec | Outperform |
2019-08-23 | 再開されました | Stephens | Overweight |
2019-07-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
2018-12-17 | アップグレード | CL King | Neutral → Buy |
2018-11-12 | ダウングレード | CL King | Buy → Neutral |
2018-09-26 | 開始されました | H.C. Wainwright | Neutral |
2017-12-08 | 開始されました | Citigroup | Buy |
2017-12-05 | 開始されました | JP Morgan | Overweight |
2017-11-13 | 開始されました | CL King | Buy |
2017-10-02 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
2017-07-21 | 開始されました | William Blair | Outperform |
2017-02-13 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Repligen Corp (RGEN) 最新ニュース
Here's Why Repligen (RGEN) is a Strong Growth Stock - Yahoo Finance
Repligen FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World
What analysts say about Repligen Corporation stockExplosive portfolio gains - PrintWeekIndia
Envestnet Asset Management Inc. Reduces Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corp to Release Q2 2025 Financial Results and Host Conference Call on July 29, 2025. - AInvest
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
M&T Bank Corp Reduces Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen to Report Second Quarter 2025 Financial Results - The Globe and Mail
Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 - Quiver Quantitative
How KEY.PRK stock performs during market volatilityFree Consultation - Newser
Why DOCU stock attracts strong analyst attentionHigh Potential Shares - Newser
How Life360 Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser
Protein Purification and Isolation Market Size to Surpass USD 33.02 Billion by 2034 - BioSpace
Parnassus Mid Cap Growth Fund Q2 2025 Commentary - Seeking Alpha
Parnassus Mid Cap Fund Q2 2025 Commentary - Seeking Alpha
Why Repligen Corporation stock attracts strong analyst attentionInstant Stock Updates - Newser
What makes ScanSource Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser
What makes HUTCHMED (China) Limited Depositary Receipt stock price move sharplyFree Join Group - Newser
How Repligen Corporation stock performs during market volatility200 Percent Profit Outlook - Newser
Why Sphere 3D Corp. stock attracts strong analyst attentionFree Stock Trading Community - Newser
Why ROAD stock attracts strong analyst attentionTop Analyst Picks - Newser
Evercore ISI Cuts Repligen (NASDAQ:RGEN) Price Target to $130.00 - Defense World
Repligen And 2 Other Stocks That May Be Trading Below Estimated Value - Yahoo Finance
GAMMA Investing LLC Boosts Holdings in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Purchased by KBC Group NV - Defense World
Fluor Corporation (NYSE:FLR) Shares Sold by Amalgamated Bank - Defense World
Wall Street Zen Downgrades Repligen (NASDAQ:RGEN) to Hold - Defense World
Improving Process Reliability in mAb Manufacturing - Genetic Engineering and Biotechnology News
Barclays initiates Repligen stock with overweight rating on bioprocessing strength - Investing.com
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey
Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025 - Yahoo Finance
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada
Repligen at William Blair Conference: Innovation Drives Growth - Investing.com
Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus
Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance
Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus
Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK
Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance
Repligen at RBC Capital Markets: Strategic Growth Insights - Investing.com Australia
Repligen Corp (RGEN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):